Local News: Gibsonton, FL 

 | 

Sign Up

 | 

Sign In

Advertisment

Barr Laboratories

Barr Laboratories Wire

Comprehensive News Feed for Barr Laboratories.

Results 1 - 20 of 38 in Barr Laboratories

  1. Market Report / TA-25 up 1.2% for the day, 0.7% for the weekRead the original story

    Thursday Dec 10 | Haaretz

    Tel Aviv stocks rose strongly on the last trading day of the week yesterday. The optimism on the Tel Aviv Stock Exchange took over in the footsteps of Wall Street the day before and major European markets yesterday.

    Comment?

    Related Topix: Israel, Hamerkaz, Israel, Tel Aviv, Israel, World News, Financial Markets

  2. Birth Control Lawsuits Affecting Memphians

    Wednesday Dec 9 | The Daily News

    ... some women - " have been tough to miss. The birth control pills are manufactured by Bayer Healthcare and Barr Laboratories. Meanwhile, Memphis-based personal injury firm Nahon, Saharovich & Trotz PLC has seen "several dozen cases and we get more ...

    Comment?

    Related Topix: Stroke, Medicine, Health, Aspirin (generic), Bayer, Alka-Seltzer, Medication, Biotech, Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Opinion

  3. Cephalon Settles Barr ChallengeRead the original story

    Nov 25, 2009 | Zacks Analyst Blog

    Analyst Report ) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical .

    Comment?

    Related Topix: Biotech, Pharmaceuticals, Healthcare Industry, Teva Pharmaceutical Industries, Marketing

  4. Emergency contraception: coming soon to a teenager near youRead the original story w/Photo

    Apr 23, 2009 | Salon.com

    As you may remember, last month a judge ordered the FDA to begin distributing Plan B, the morning-after pill, over the counter to women ages 17 and up.

    Comment?

    Related Topix: George Bush, W.

  5. Cephalon, Barr Settle Fentora DisputeRead the original story

    Nov 13, 2009 | Drugs.com

    Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday.

    Comment?

    Related Topix: Biotech, Cephalon, Medicine, Healthcare Industry, Pharmaceuticals, Health, Pain, Watson Pharmaceuticals, Food and Drug Administration, Lymphoma

  6. Cephalon, Inc., Barr Pharmaceuticals, Inc. Settle Patent Infringement SuitRead the original story

    Nov 13, 2009 | BioSpace

    Cephalon Inc said on Thursday it has come to an agreement to settle its patent infringement dispute with Barr Pharmaceuticals over the pain drug Fentora. Read at Reuters

    Comment?

    Related Topix: Biotech, Cephalon, Medicine, Healthcare Industry, Pharmaceuticals

  7. Nice Quarter, Teva. What Will You Buy Next?Read the original story

    Nov 3, 2009 | The Motley Fool

    Sometimes, using equity to grow can come back to bite you . Teva Pharmaceuticals ' acquisition of Barr Pharmaceuticals helped boost its net income in the third quarter, but its earnings per share fell as that larger pie was split into a greater number of pieces.

    Comment?

    Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Novartis, Mylan Laboratories, Elan Corporation Plc

  8. Dextroamphetamine, Amphetamine 20mg TabletsRead the original story

    Aug 13, 2009 | Drugs.com

    Dextroamphetamine Saccharate/Amphetamine Aspartate/Dextroamphetamine Sulfate/Amphetamine Sulfate Barr Laboratories, Inc.

    Comment?

    Related Topix: Medicine, Medication, Adderall, Dextroamphetamine/Amphetamine (generic), Dexedrine, Dextroamphetamine Sulfate (generic), Biotech, Pharmaceuticals, Healthcare Industry, Leukemia, Health, Influenza, H1N1 Influenza / Swine Flu

  9. Covidien gets approval for generic pain drug ActiqRead the original story w/Photo

    Oct 30, 2009 | Bioscience Technology

    Covidien PLC said Friday it expects to start selling a generic version of the painkiller Actiq in early 2010.

    Comment?

    Related Topix: Food and Drug Administration, Marketing, Medicine, Biotech, Cephalon, Healthcare Industry

  10. Watson and Barr Settle Lawsuit Over Oxytrol

    Oct 29, 2009 | Pharmaceutical Online

    ... company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol (Oxybutynin Transdermal System, 3.9mg/24hr.) product. On August ...

    Comment?

    Related Topix: Biotech, Watson Pharmaceuticals, Medicine, Pharmaceuticals, Healthcare Industry, Marketing

  11. Watson and Barr Settle Lawsuit Over Oxytrol

    Oct 28, 2009 | Pharmaceutical Processing

    ... company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol@ (Oxybutynin Transdermal System, 3.9mg/24hr.) product. On ...

    Comment?

    Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Watson Pharmaceuticals

  12. U.S. Court of Appeals Enforces Subpoenas in FTCa s Androgel...Read the original story

    Oct 27, 2009 | Federal Trade Commission

    The Federal Trade Commission today announced two subpoena enforcement actions challenging tactics that delay agency investigations.

    Comment?

    Related Topix: District of Columbia Circuit Court of Appeals, US News

  13. Sun Pharma backs out of Forest patent rowRead the original story

    Oct 23, 2009 | Express India

    ... that faced the lawsuit include Cobalt Laboratories, Teva Pharmaceuticals, Upsher-Smith Laboratories and Barr Laboratories. These companies had applied to USFDA to obtain the manufacturing and marketing approval for adamantane (Namenda). Forest Labs ...

    Comment?

    Related Topix: World News, India, New Delhi, India, Haryana, India, Biotech, Medicine, Forest Labs, Healthcare Industry

  14. Joseph G. Darling and Scott E. Coleridge Join Serica Technologies' Board of DirectorsRead the original story

    Oct 15, 2009 | BusinessWire

    ... of Kingston Diagnostics, developer of the first whole-blood cholesterol test. After the sale of FEI to Barr Laboratories in 2005, Mr. Coleridge joined Morningside Technology Advisory, LLC working on Healthcare and Life Science Investments. He is a ...

    Comment?

    Related Topix: Marketing, Illinois, Women's Health, Health

  15. Teva (TEVA): Baby-boomers give boost to genericsRead the original story

    Oct 14, 2009 | Blogging Stocks

    Filed under: International markets , Newsletters , Teva Pharm Indus ADR , Stocks to Buy , Israel , Obama Picks "The health care picks in our growth portfolio should prosper whatever the outcome of the raging health care debate," suggests growth stock specialist Stephen Leeb .

    Comment?

    Related Topix: Biotech, Teva Pharmaceutical Industries, Financial Markets

  16. Morning-after pill sales jump as U.S. access easesRead the original story

    Oct 14, 2009 | Canada.com

    Sales of the Plan B "morning-after pill" nearly doubled in the past year, exceeding expectations after the U.S. government allowed adults to buy the emergency contraceptive without a prescription.

    Comment?

    Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Pharmaceuticals, Healthcare Industry

  17. Research and Markets: Partnering in the Global Generics Industry...Read the original story

    Oct 14, 2009 | Business Wire

    Research and Markets: Partnering in the Global Generics Industry 2009: a Guide to Companies - Now Available Identify merger, acquisition and partner candidates in the rapidly changing global generics market and collaboration runs throughout the generic industry.

    Comment?

  18. Shire and Sandoz Settle Adderall XR Patent SuitsRead the original story

    Oct 14, 2009 | Pharmaceutical Processing

    ... are valid and enforceable. Shire has already entered similar settlements with Impax Laboratories Inc. and Barr Laboratories, a unit of Teva Pharmaceutical Industries Ltd. It said there are no remaining patent challenges related to generic versions ...

    Comment?

    Related Topix: Biotech, Shire plc, Food and Drug Administration

  19. Shire settles pending Adderall XR litigation with SandozRead the original story

    Oct 13, 2009 | Medical News

    ... XR(R). No payments to Sandoz are involved in the settlement agreement. Impax Pharmaceuticals Inc. and Barr Laboratories Inc. remain the only authorized generic supplier of ADDERALL XR. The litigation involves a patent infringement lawsuit covering ...

    Comment?

    Related Topix: Biotech, Shire plc, Healthcare Law, Food and Drug Administration, Law, Health

  20. Shire and Sandoz Settle all Pending Litigation Concerning Adderall XR

    Oct 13, 2009 | Drugs.com

    ... XR(R). No payments to Sandoz are involved in the settlement agreement. Impax Pharmaceuticals Inc. and Barr Laboratories Inc. remain the only authorized generic supplier of ADDERALL XR. The litigation involves a patent infringement lawsuit covering ...

    Comment?

    Related Topix: Biotech, Shire plc, Healthcare Law, Law, Food and Drug Administration, Medicine, Pharmaceuticals, Healthcare Industry, ADHD, Health